Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure

NCT01731002 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

224

Enrollment

INDUSTRY

Sponsor class

Conditions

Ocular Hypertension
Open Angle Glaucoma

Interventions

DRUG: AR-13324 Ophthalmic Solution 0.01%
DRUG: AR-13324 Ophthalmic Solution 0.02%
DRUG: Latanoprost ophthalmic solution 0.005%

Sponsor

Aerie Pharmaceuticals